The aim of this study was to quantify the gene expression levels of E-cadherin in oral cancer patients and controls and to evaluate their association with tumor, node, metastasis (TNM) stage, persistence, recurrence, death, and response to therapy. The gene discussed is CDH1; the disease is lip and oral cavity carcinoma.